Treatment options for people with glioma, a type of brain cancer
13 September 2023 - BMS, the supplier of lomustine, a treatment used for a type of brain cancer called glioma, is discontinuing its product in New Zealand.
The discontinuation is global, affecting other countries including Canada and Australia.